Advanced maternal age (AMA) is the medical term for any pregnancy in a woman aged 35 or older at the time of delivery. The risk of chromosomal abnormalities, pregnancy complications, and cesarean delivery rises measurably at this threshold. With proper prenatal care, the majority of women over 35 in the United States deliver healthy babies.
What Advanced Maternal Age Means Clinically
The term advanced maternal age was standardized by the American College of Obstetricians and Gynecologists (ACOG) because chromosomal risk at amniocentesis first equals its procedural miscarriage risk at age 35. Before that age, the test’s own risk outweighed the chromosomal risk it was meant to detect.
Some providers also use the term very advanced maternal age (VAMA) for pregnancies at age 45 or older, where risk profiles escalate well beyond those seen at 35 to 44.
How Common AMA Pregnancies Are in the United States
Births to women over 35 have risen for four consecutive decades. The CDC reports a birth rate of approximately 52.8 per 1,000 women aged 35 to 39, and approximately 11.8 per 1,000 for women aged 40 to 44. The average age of a first-time mother in the U.S. is now approximately 27, compared to 21 in 1972.
Chromosomal Abnormality Risk by Maternal Age
Chromosomal abnormality risk rises with every year of maternal age, with the sharpest increases occurring after 37. The figures below reflect ACOG population-based estimates.
| Maternal Age | Risk of Down Syndrome (Trisomy 21) | Risk of Any Chromosomal Abnormality |
|---|---|---|
| 25 | 1 in 1,250 | 1 in 476 |
| 30 | 1 in 952 | 1 in 385 |
| 35 | 1 in 385 | 1 in 192 |
| 37 | 1 in 245 | 1 in 127 |
| 40 | 1 in 106 | 1 in 66 |
| 43 | 1 in 50 | 1 in 30 |
| 45 | 1 in 30 | 1 in 20 |
The three most common trisomies linked to advanced maternal age are Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). Sex chromosome abnormalities also increase in frequency beyond 35.
How Fertility Changes After 35
Natural monthly conception rates drop to approximately 5% per cycle by age 40, compared to roughly 20 to 25% per cycle in the mid-twenties. ACOG advises women over 35 to seek a fertility evaluation after just 6 months of unprotected intercourse, rather than the standard 12 months applied to younger women.
For women using in vitro fertilization (IVF) with their own eggs, live birth rates per retrieval cycle are approximately 30 to 35% at ages 35 to 37, falling to 15 to 20% at 38 to 40, and below 5% at 43 and older, according to CDC ART surveillance data.
Pregnancy Complications That Occur More Often After 35
Five specific complications occur at measurably higher rates in AMA pregnancies, each rising further as age increases beyond 35.
Gestational Diabetes
Gestational diabetes mellitus (GDM, meaning high blood sugar that develops during pregnancy and typically resolves after delivery) occurs in approximately 7 to 9% of all U.S. pregnancies, and women over 35 face roughly twice that rate compared to women in their twenties.
GDM raises the likelihood of delivering a macrosomic baby (a baby significantly larger than average), increases cesarean delivery rates, and is associated with elevated long-term Type 2 diabetes risk for both mother and child.
Preeclampsia
Preeclampsia, a pregnancy complication defined by high blood pressure and signs of organ damage appearing after 20 weeks of gestation, affects approximately 5 to 8% of pregnancies overall and occurs at 2 to 4 times that rate in women 40 and older.
Severe preeclampsia can progress to eclampsia (pregnancy-related seizures), HELLP syndrome (a serious blood and liver disorder), stroke, or kidney failure, making early detection critical for AMA patients.
Placenta Previa
Placenta previa, a condition where the placenta partially or fully covers the cervical opening, occurs at approximately 2 to 3 times the baseline rate in women over 35 compared to women in their twenties.
Placenta previa typically causes painless bleeding in the second or third trimester and usually requires cesarean delivery to avoid life-threatening hemorrhage.
Placental Abruption
Placental abruption, defined as premature separation of the placenta from the uterine wall before delivery, increases in frequency with maternal age and can cause severe maternal hemorrhage and fetal oxygen deprivation requiring emergency delivery.
This page tells you how many days old you are and on which day you were born. The number of leap days tells you how many February 29’s you’ve experienced.
Cesarean Delivery
C-section rates in women 40 and older exceed 45 to 50% in many U.S. hospitals, compared to the national average of approximately 32% across all maternal ages. Higher rates of labor induction, fetal intolerance of labor, and placental complications all contribute to this difference.
Risk Comparison Across AMA Age Bands
Complication rates differ meaningfully between the 35 to 39, 40 to 44, and 45 and older age groups, as shown in the table below.
| Complication | Ages 35-39 | Ages 40-44 | Ages 45+ |
|---|---|---|---|
| Gestational diabetes | Moderately elevated | Approx. 2x baseline | 3x+ baseline |
| Preeclampsia | Slightly elevated | 2-3x baseline | 4x+ baseline |
| Cesarean delivery | ~35-38% | ~45-50% | ~55%+ |
| Any chromosomal abnormality | Rising sharply | High | Very high |
| Stillbirth | ~1.5x baseline | ~2x baseline | ~2.5-3x baseline |
Miscarriage and Stillbirth Risk After 35
Miscarriage rates rise steeply with age, reaching approximately 40 to 50% of recognized pregnancies by age 40, compared to approximately 10 to 15% at age 25, according to published obstetric data. The large majority of these losses involve chromosomal abnormalities in the embryo.
Stillbirth, defined in the United States as fetal death at or after 20 weeks of gestation, approximately doubles in risk between women in their mid-twenties and women over 40.
ACOG recommends offering non-stress tests (NSTs) and biophysical profiles beginning at 36 to 37 weeks for AMA patients, with earlier surveillance starting at 32 to 34 weeks when additional risk factors are present.
Prenatal Screening and Diagnostic Testing Options
Screening tests assess the probability of a chromosomal problem without definitive confirmation. Diagnostic tests provide a definitive chromosomal answer with a small procedural risk.
Screening Tests (Non-Invasive)
- Cell-free fetal DNA (cfDNA/NIPT): a blood draw after 10 weeks that analyzes fetal DNA fragments circulating in maternal blood. NIPT detects Down syndrome with sensitivity exceeding 99%, according to ACOG.
- First-trimester combined screening: nuchal translucency (fluid behind the fetal neck) ultrasound combined with blood tests for PAPP-A and hCG, performed between 11 and 13 weeks.
- Quad screen: a blood panel measuring AFP, hCG, estriol, and inhibin A, performed between 15 and 20 weeks.
Diagnostic Tests (Invasive, Definitive)
- Chorionic villus sampling (CVS): placental tissue sampling performed between 10 and 13 weeks, with a procedural miscarriage risk of approximately 0.5 to 1%.
- Amniocentesis: amniotic fluid sampling performed after 15 weeks, with a procedural miscarriage risk of approximately 0.1 to 0.3% at experienced centers.
Both diagnostic procedures provide a complete fetal karyotype (a full map of the chromosomes) and can detect hundreds of chromosomal conditions with near-certainty. ACOG supports offering diagnostic testing to all women, not only those over 35.
Ultrasound Monitoring Schedule for AMA Pregnancies
AMA patients typically receive a more intensive ultrasound schedule than younger women, beginning in the first trimester and continuing through delivery.
| Timing | Test | Purpose |
|---|---|---|
| 11-13 weeks | Nuchal translucency ultrasound | Screen for chromosomal abnormalities |
| 18-20 weeks | Detailed anatomy scan (often with MFM specialist) | Full structural evaluation |
| Every 4 weeks from ~28 weeks | Growth ultrasound | Detect intrauterine growth restriction (IUGR) |
| 32-37 weeks onward | Non-stress tests (NSTs) and biophysical profiles | Monitor fetal wellbeing, reduce stillbirth risk |
Many AMA patients are co-managed by a maternal-fetal medicine (MFM) specialist (a high-risk obstetrics subspecialist also called a perinatologist) alongside their primary OB-GYN.
Preexisting Conditions That Compound AMA Risk
Older maternal age commonly coincides with chronic health conditions that independently raise obstetric risk, compounding the effects of age alone.
| Preexisting Condition | How It Compounds AMA Risk |
|---|---|
| Chronic hypertension | Multiplies preeclampsia and placental insufficiency risk |
| Type 2 diabetes | Raises fetal malformation, macrosomia, and stillbirth risk |
| Thyroid disease | Affects fetal neurological development; more common over 35 |
| Obesity (BMI 30+) | Multiplies gestational diabetes, C-section, and blood clot risk |
| Uterine fibroids | More prevalent with age; can complicate placentation and delivery |
| Prior pregnancy losses | Common by 40; may require additional monitoring or medication |
Women over 35 with any of these conditions benefit from preconception counseling (a consultation with an OB-GYN or MFM specialist before trying to conceive) to optimize disease management before pregnancy begins.
Steps That Reduce Risk Before and During Pregnancy
Six evidence-based steps from ACOG and the CDC measurably reduce risk for women over 35 planning or entering pregnancy.
- Begin folic acid at 400 to 800 micrograms daily at least 3 months before conception to reduce neural tube defect risk.
- Achieve a healthy BMI before conception. A BMI above 30 substantially amplifies every AMA risk category independently.
- Stabilize chronic conditions including hypertension, diabetes, and thyroid disorders on pregnancy-safe medications before conceiving.
- Complete genetic carrier screening before conception to identify whether both partners carry recessive conditions such as cystic fibrosis, sickle cell disease, or spinal muscular atrophy.
- Eliminate alcohol and tobacco completely. Smoking accelerates ovarian aging and raises miscarriage, placental abruption, and preterm birth risk.
- Review all current medications with a provider. Some commonly used drugs in older adults, including certain blood pressure medications and statins, require substitution before pregnancy.
Delivery Timing and Labor Management After 35
Many providers recommend induction of labor at 39 to 40 weeks for uncomplicated AMA pregnancies, based on evidence that prolonging pregnancy beyond 40 weeks raises stillbirth risk disproportionately in older women.
For women over 40 with any additional risk factor, most MFM specialists target delivery no later than 38 to 39 weeks.
The ARRIVE trial (A Randomized Trial of Induction Versus Expectant Management) demonstrated that elective induction at 39 weeks in low-risk pregnancies does not increase cesarean rates and may carry a modest safety benefit.
Frequently Asked Questions
What exactly is advanced maternal age?
Advanced maternal age (AMA) is the obstetric term for a pregnancy in a woman who is 35 or older at the time of delivery. The designation exists because chromosomal abnormality risk, pregnancy complication rates, and cesarean delivery rates all rise measurably at this threshold. Being classified as AMA does not make a pregnancy automatically high-risk, but it triggers additional screening and monitoring protocols.
Why is 35 the cutoff for advanced maternal age?
The age 35 threshold was established because the statistical risk of a chromosomal abnormality first equals the procedural miscarriage risk of amniocentesis at that age, making the test’s benefit outweigh its risk. It is also the point where clinically significant decline in egg quality and fertility becomes measurable in population data. The cutoff has been retained in ACOG guidelines even as prenatal testing technology has improved.
Does advanced maternal age automatically mean a high-risk pregnancy?
Not automatically. Many women over 35 have uncomplicated pregnancies and deliver healthy babies without additional intervention. Overall risk depends on the full clinical picture, including preexisting health conditions, BMI, multiple gestation, and prior obstetric history. Women with no additional risk factors beyond age are often managed similarly to younger women with the addition of closer fetal surveillance.
What prenatal tests are recommended for women over 35?
ACOG recommends offering cfDNA/NIPT screening as early as 10 weeks, first-trimester nuchal translucency ultrasound at 11 to 13 weeks, and diagnostic testing via CVS or amniocentesis for women who want a definitive chromosomal result. A detailed anatomy ultrasound is performed at 18 to 20 weeks, and third-trimester growth scans along with non-stress tests are routinely added for AMA pregnancies.
What is the Down syndrome risk at age 35 compared to age 40?
At age 35, the risk of a Down syndrome pregnancy is approximately 1 in 385. By age 40, that risk rises to approximately 1 in 106. By age 45, it reaches approximately 1 in 30. These estimates are at the time of delivery; mid-pregnancy risk is modestly higher because chromosomally affected pregnancies are lost at elevated rates before delivery.
Can a woman over 40 have a healthy baby?
Yes. The majority of women who conceive at 40 to 44 and receive appropriate prenatal care deliver healthy babies. Elevated risk does not mean poor outcome. With thorough screening, active management of any complications that arise, and delivery planning appropriate to the patient’s specific risk profile, healthy outcomes are common and achievable.
What is very advanced maternal age?
Very advanced maternal age (VAMA) refers to pregnancy at age 45 or older. At this threshold, the risk of any chromosomal abnormality is approximately 1 in 20, most successful pregnancies rely on donor eggs rather than the patient’s own eggs when ART is used, and medical complication rates rise steeply above those seen at 35 to 44. VAMA pregnancies are almost always co-managed by a maternal-fetal medicine specialist.
How does advanced maternal age affect miscarriage risk?
Miscarriage risk rises sharply with age. By age 40, approximately 40 to 50% of recognized pregnancies end in miscarriage, compared to approximately 10 to 15% at age 25. The large majority of these losses are caused by chromosomal abnormalities in the embryo rather than problems with the uterus or maternal health.
Should I see a specialist if I am pregnant over 35?
Women over 35 are often managed successfully by their regular OB-GYN without specialist referral if no additional risk factors are present. Referral to a maternal-fetal medicine (MFM) specialist is typically recommended when AMA is combined with preexisting hypertension, diabetes, thyroid disease, prior pregnancy complications, multiples, or abnormal screening results. Most providers refer all women over 40 for at least a consultation with an MFM specialist.
What is NIPT and how accurate is it for older mothers?
Non-invasive prenatal testing (NIPT), also called cfDNA screening, is a blood test drawn after 10 weeks that analyzes fragments of fetal DNA circulating in the maternal bloodstream to screen for chromosomal abnormalities. For Down syndrome, NIPT has sensitivity exceeding 99% and a false-positive rate below 0.1% in the general population. The test performs especially well in AMA pregnancies because the higher pre-test probability of chromosomal abnormalities increases the reliability of a positive result.